imageSlide
Clinical Study Report (CSR) Synopses
60px
medium
false
hands using laptop keyboard and mouse
white
spacer
large
primary
large
Lilly provides the ability to search for Clinical Study Report (CSR) Synopses
for Phase 2, Phase 3 and Phase 4 clinical trials that initiated on or after
October 15, 2002, and studied the effects of medicines that are approved
for use in the United States (U.S.) and the European Union (EU).
for Phase 2, Phase 3 and Phase 4 clinical trials that initiated on or after
October 15, 2002, and studied the effects of medicines that are approved
for use in the United States (U.S.) and the European Union (EU).
32px
Lilly is working to complete the transfer of these CSR Synopses from different sources and will
continue to update the search with historical trials. Newly completed studies will be provided in
a timely manner for approved medicines after the approval of an indication has occurred in the
U.S. and the EU and the primary peer-reviewed publication is available.
continue to update the search with historical trials. Newly completed studies will be provided in
a timely manner for approved medicines after the approval of an indication has occurred in the
U.S. and the EU and the primary peer-reviewed publication is available.
20px
spacer
large
The information is not intended to replace the advice of your physician and is not intended to
promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of
Lilly products. If you have any questions regarding any information contained in this link, please
consult with your physician.
promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of
Lilly products. If you have any questions regarding any information contained in this link, please
consult with your physician.
20px
spacer
large
Trade name
16px
Generic name
Adcirca®
16px
Tadalafil
16px
Alimta®
16px
Pemetrexed
16px
BAQSIMI™
16px
Nasal Glucagon Powder
16px
Cialis®
16px
Tadalafil
16px
Cymbalta®
16px
Duloxetine
16px
Cyramza®
16px
Ramucirumab
16px
Effient®
16px
Prasugrel
16px
Emgality®
16px
Galcanezumab
16px
Evista®
16px
Raloxifene
16px
Forteo®
16px
Teriparatide
16px
Gemzar®
16px
Gemcitabine
16px
Glucagon™
16px
Glucagon for Injection
16px
Humalog®
16px
Insulin Lispro Injection
16px
Humatrope®
16px
Somatropin
16px
Humulin®
16px
Human Insulin
16px
Lartruvo™
16px
Olaratumab
16px
Lyumjev™
16px
Insulin Lispro-aabc Injection
16px
Mounjaro®
16px
Tirzepatide
16px
Olumiant®
16px
Baricitinib
16px
Omvoh®
16px
Mirikizumab
16px
Portrazza®
16px
Necitumumab
16px
Prozac®
16px
Fluoxetine
16px
Reyvow®
16px
Lasmiditan
16px
Strattera®
16px
Atomoxetine
16px
Symbyax®
16px
Olanzapine and Fluoxetine
16px
Taltz®
16px
Ixekizumab
16px
Trulicity®
16px
Dulaglutide
16px
Verzenio®
16px
Abemaciclib
16px
Yentreve®
16px
Duloxetine
16px
Zepbound®
16px
Tirzepatide
16px
Zyprexa®
16px
Olanzapine
16px
Search CSR synopses
36px
Use this form to search the CSRs.